229 related articles for article (PubMed ID: 12618906)
1. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
[TBL] [Abstract][Full Text] [Related]
2. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
[TBL] [Abstract][Full Text] [Related]
3. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
5. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
[TBL] [Abstract][Full Text] [Related]
6. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
Nekrep N; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome.
Nekrep N; Geyer M; Jabrane-Ferrat N; Peterlin BM
Mol Cell Biol; 2001 Aug; 21(16):5566-76. PubMed ID: 11463838
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics of the Bare lymphocyte syndrome.
Masternak K; Muhlethaler-Mottet A; Villard J; Peretti M; Reith W
Rev Immunogenet; 2000; 2(2):267-82. PubMed ID: 11258423
[TBL] [Abstract][Full Text] [Related]
10. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
[TBL] [Abstract][Full Text] [Related]
11. Associations and interactions between bare lymphocyte syndrome factors.
DeSandro AM; Nagarajan UM; Boss JM
Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
[TBL] [Abstract][Full Text] [Related]
13. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
[TBL] [Abstract][Full Text] [Related]
14. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.
Gobin SJ; Peijnenburg A; van Eggermond M; van Zutphen M; van den Berg R; van den Elsen PJ
Immunity; 1998 Oct; 9(4):531-41. PubMed ID: 9806639
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
Brickey WJ; Wright KL; Zhu XS; Ting JP
J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
[TBL] [Abstract][Full Text] [Related]
16. The bare lymphocyte syndrome and the regulation of MHC expression.
Reith W; Mach B
Annu Rev Immunol; 2001; 19():331-73. PubMed ID: 11244040
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter.
Zhu XS; Linhoff MW; Li G; Chin KC; Maity SN; Ting JP
Mol Cell Biol; 2000 Aug; 20(16):6051-61. PubMed ID: 10913187
[TBL] [Abstract][Full Text] [Related]
18. DNA binding domain of RFX5: interactions with X-box DNA and RFXANK.
Chakraborty M; Sengupta A; Bhattacharya D; Banerjee S; Chakrabarti A
Biochim Biophys Acta; 2010 Oct; 1804(10):2016-24. PubMed ID: 20637319
[TBL] [Abstract][Full Text] [Related]
19. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
[TBL] [Abstract][Full Text] [Related]
20. A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.
Cai YQ; Zhang H; Wang XZ; Xu C; Chao YQ; Shu Y; Tang LF
Open Forum Infect Dis; 2020 Aug; 7(8):ofaa314. PubMed ID: 32875002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
